Nucci Paolo

Preparing the ocular surface for glaucoma filtration surgery: an unmet clinical need.

Moreover, we reported the most exploited measures to mitigate the OSD before surgery, the possible reasons underlying the absence of shared approaches, and the upcoming area of intervention to preserve the OS health during glaucoma management.

Risk Factors for Failure in Glaucoma Patients Undergoing Microshunt Implantation.

This study identified risk factors for Microshunt failure, highlighting the importance of high intraoperative MMC dose and careful patient selection to optimize surgical success.

Decade-Long Profile of Imaging Biomarker Use in Ophthalmic Clinical Trials.

Imaging biomarkers are increasingly used in published CTs in ophthalmology.

Posner-Schlossman Syndrome European Study Group: study protocol and baseline patients characteristics of a multicentre study.

The PSS-ESG is the first multicentre study aimed to collect a comprehensive dataset of patients with PSS in non-Asian countries.

Correction: Managing the ocular surface after glaucoma filtration surgery: an orphan topic.

Managing the ocular surface after glaucoma filtration surgery: an orphan topic.

Clinicians are encouraged to routinely include the OS evaluation after GFS and to consider proper management when the occurrence of PGS-OSD worsen the patient's QOL or exert negative effects to the FB functionality.

Effectiveness and safety of XEN45 implant over 12 months of follow-up: data from the XEN-Glaucoma Treatment Registry.

Over 1-year follow-up, XEN45 alone or in combination with phacoemulsification, had comparable success rates and effectively and safely lowered IOP and the need for OHM.

The Ocular Surface in Medically Controlled Glaucoma: An In Vivo Confocal Study.

In stable MCPOAG patients without dry eye history, the ocular surface changes due to antiglaucoma medications are mostly subclinical.